Breaking News
Investing Pro 0
Cyber Monday Extended SALE: Up to 60% OFF InvestingPro+ CLAIM OFFER
Close

Fresenius SE & Co KGAA O.N. (FREG)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
26.61 -0.06    -0.22%
12:19:00 - Delayed Data. Currency in EUR ( Disclaimer )
Type:  Equity
Market:  Germany
ISIN:  DE0005785604 
S/N:  578560
  • Volume: 108,175
  • Bid/Ask: 26.42 / 26.61
  • Day's Range: 26.20 - 26.98
Fresenius SE 26.61 -0.06 -0.22%

Fresenius AG Company Profile

 
Get an in-depth profile of Fresenius SE & Co KGAA O.N., including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryHealth Care Providers & Services
SectorHealthcare
Employees

318647

Equity Type

ORD

Fresenius SE & Co. KGaA, a health care company, provides products and services for dialysis, hospitals, and outpatient medical care. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, hemodialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of therapy and care ill patients. This segment offers IV drugs, including intravenously administered generic drugs for oncology, anesthetics, analgesics, anti-infectives, and critical care; parenteral and enteral nutrition products; infusion solutions and blood volume substitutes for infusion therapy; biosimilars, a biological medicine for autoimmune and oncology diseases; medical devices and disposal used to administer IV generic drugs, infusion therapies, and clinical nutrition products; and transfusion products for collection of blood components and corporeal therapies. The Fresenius Helios segment operates 90 hospitals, approximately 130 outpatient clinics, and 6 prevention centers in Germany; and 49 hospitals, 88 outpatient clinics, and approximately 300 risk prevention centers in Spain. This segment also provides services in the field of fertility treatments through 33 clinics and additional 39 sites across 10 countries on 3 continents. The Fresenius Vamed segment manages projects and offers services for hospitals and other health care facilities. This segment provides project development, planning, and turnkey construction services, as well as maintenance, technical management, and operational management services. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.

Contact Information

Phone 49 6172 608 2487
Fax 49 6172 608 2488

Top Executives

Name Age Since Title
Gerd E. Krick 84 2003 Honorary Chairman of Supervisory Board
Konrad Kölbl 63 2007 Member of Supervisory Board
Oscar Romero De Paco 48 2016 Member of Supervisory Board
Iris Low-Friedrich 62 2016 Member of Supervisory Board
Frauke Lehmann 59 2016 Member of Supervisory Board
D. Michael Albrecht 73 2011 Member of Supervisory Board
Michael Diekmann 68 2015 Deputy Chairman of the Supervisory Board
Wolfgang Kirsch 67 2021 Chairman of Supervisory Board
Bernd Behlert 64 2018 Member of Supervisory Board
Grit Genster 49 2020 Deputy Chairman of the Supervisory Board
Stefanie Balling 54 2016 Member of Supervisory Board
Christoph Zindel 61 2022 Member of Supervisory Board
Susanne Zeidler 61 2022 Member of the Supervisory Board
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

FREG Comments

Write your thoughts about Fresenius AG
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Jasper Wyatt
Jasper Wyatt 30 minutes ago
Saved. See Saved Items.
This comment has already been saved in your Saved Items
The reason I 🌏 I stopped trading on all these other platforms and focused on 👉💬 🆅︎🅸︎🅲︎🆃︎🅾︎🆁︎🅸︎🅰︎ 🅴︎ 🅼︎🅾︎🆁︎🅶︎🅰︎🅽︎ on🅵︎🅰︎🅲︎🅴︎🅱︎🅾︎🅾︎🅺︎ 🎉 is that they have a strong liquidity system for guaranteed solvency, also a nice custom signal for better trades, always appreciate your time , analysis, perspective and great attitude. God bless you and your family ma'am 🙏❤️ you can visit her for guidance too 🆆🅷🅰🆃🆂🅰🅿🅿 +➍➍➐➌➐➑➎⓿➒➒➌⓿
Andreas Lang
Andreas Lang Aug 05, 2022 5:42AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
The CEO of the company has said he will stock up his personal account in investor conference. That's always an extremely good signal of underlying value. Yes the news is not good and it's been consistent bad for FMC. But these companies are large businesses and continue to grow. Over punished.
DONNY WAGNER
DONNY WAGNER May 12, 2021 9:06AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
The long term chart gives the direction
Thomas Tribal
Thomas Tribal Aug 10, 2020 12:15PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
undervalued
Theodoridis Thomas
Theodoridis Thomas Mar 23, 2016 3:13PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
No that was a mistake to sell you. You go probably higher. Tomorrow we tell a target price, we need also some clear image from other 3 components.
Forex Signals
Forex Signals Jan 16, 2016 12:50AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
downtrend triangle at 56.70
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email